We assessed the impact of papillary renal cell carcinoma (RCC) on oncological outcomes after partial nephrectomy compared to clear cell RCC in patients with pathologic T1a RCC.
INTRODUCTION AND OBJECTIVES:
We assessed the impact of papillary renal cell carcinoma (RCC) on oncological outcomes after partial nephrectomy compared to clear cell RCC in patients with pathologic T1a RCC.
METHODS: After excluding patients with synchronous multiple renal tumors, familial renal cell carcinoma, pathologic T1b or greater disease, and metastatic disease, 759 patients with clear cell and 84 patients with papillary RCC were included for the analysis. We compared the impacts of papillary RCC with clear cell RCC on oncologic outcomes. Median follow-up duration was 67 months.
RESULTS: There was no differences in patient and tumor characteristics between the 2 groups except for Fuhrman grade (p¼0.006). In Kaplan-Meier analysis, 5-year recurrence free survival was 98.7% in patients with clear cell RCC and 95.6% in patients with papillary RCC. However, 10-year recurrence free survival in patients with clear cell and papillary RCC was 96.1% and 73.0%, respectively (p<0.001). Median time to recurrence was 31 months in patients with clear cell RCC and 77 months in patients with papillary RCC although statistical significance was not achieved (p¼0.190). In multivariate analysis, papillary RCC (HR; 5.309, p¼0.001) was determined as a significant risk factor for recurrence after partial nephrectomy in pathologic T1a RCC patients in addition to tumor size (HR; 1.861, p¼0.038) and Fuhrman grade (¼3) (HR; 5.176, p¼0.003).
CONCLUSIONS: Recurrence after partial nephrectomy was more commonly occurred in pathologic T1a papillary RCC compared to clear cell RCC. Because median time to recurrence in papillary RCC was greater than 5-year after surgery, longer follow-up is needed for patients with papillary RCC even though pathologic stage is T1a.
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MP55-04 PERINEPHRIC VERSUS SINUS FAT INVASION IN PT3A TUMORS MANAGED BY PARTIAL NEPHRECTOMY
Pascal Mouracade*, Onder Kara, Matthew Maurice, Julien Dagenais, Ercan Malkoc, Ryan Nelson, Jeremy Reese, Jihad Kaouk, Cleveland, OH INTRODUCTION AND OBJECTIVES: With adoption of partial nephrectomy (PN), the last few years have been marked by a growth in the use of PN for complex renal masses. This has led to an overall increase in the number of tumors found to have adverse pathological features. There are two types of pathological findings in the current T3a fat invasion renal cell carcinoma (RCC): renal sinus fat invasion (SFI) and perinephric fat invasion (PFI). From an anatomical perspective, after PN, RCC with SFI could be considered more likely to develop recurrence and may be associated with worse prognosis. The aim of our study was to evaluate the influence of SFI and PFI on progression-free survival and overall survival after PN for stage pT3a RCC.
METHODS: We retrospectively reviewed our institutional review board-approved PN database. Data consisted of consecutive records of patients who underwent PN for cT1-3a renal cell carcinoma (RCC) between 2007 and 2016. Overall 1306 patients were included in this study. Of this cohort, 143 patients were staged pT3a with SFI (85 patients) or PFI (58 patients) on final pathology. Demographic, perioperative and pathological variables were reviewed. We compared the clinico-pathological characteristics, perioperative morbidity and oncological outcomes between SFI and PFI groups. Progression-free survival (PFS) and overall survival (OS) analyses were performed. Survival curves were compared using Log-rank test.
RESULTS: There were no differences between the 2 groups in terms of age, gender, race, Body mass index, Charlson comorbidity index, cTstage and surgical approach. SFI group had a higher clear cell subtype (p<0.01), Higher R.E.N.A.L score (median 9 vs. 7, p<0.01), Higher hilar (h) location (p<0.01). Positive surgical margin rate was higher in SFI group (21.1% vs. 10.3%) but the difference was not statistically significant(p¼0.09). SFI group had higher warm ischemia time (median 28 vs. 21, p<0.01), while estimated blood loss (p¼0.6), transfusion rate (p¼0.2), Clavien complications (p¼0.6) were not different between the 2 groups. After a median 28 months, there were 19 recurrences (13.3%) and 7 deaths (4.9%). When comparing the survival curves between the 2 groups, there were no differences in PFS (Log rank, p¼0.5) and OS (Log rank, p¼0.8). Tumors size (HR:1.5, 95% CI [1.1-1.9], p <0.01, and tumor grade (HR:3.6, 95% CI [1.1-4.6], p¼0.04) were independent predictors of recurrence.
CONCLUSIONS: In our cohort of patients with pT3a renal cell carcinoma following partial nephrectomy, sinus fat invasion compared to perinephric fat invasion was not associated with an increased risk of progression or death. The independent predictors of recurrence in this population were tumor size and tumor grade. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e731 multi-center study and compared to radical nephrectomy (RN) performed in the same centers for tumors of comparable diameter and VTT. Demographics, perioperative complications, functional, and oncologic outcomes were compared between the two groups. Mean, median, standard deviation, and interquartile range (IQR) were used to report continuous variables, as appropriate. Survival analysis were used to assess recurrence free survival (RFS), cancer specific survival (CSS) and overall survival (OS). Univariable (UVA) and multivariable (MVA) analyses were used to evaluate variables predicting complications, OS, CSS and RFS, and end-stage renal disease (ESRD, eGFR<30). RESULTS: Overall, 63 cases and 176 control were enrolled in the study. VTT was unsuspected pre-operatively in 46 (73%) of PN cases. Any grade and high grade postoperative complications were recorded in 41.9% and 22.2% for PN patients, respectively, and in 21.7% and 7.9% for RN patients, respectively (p values <0.05). Once adjusted for covariates, PN was associated with a significantly higher risk of any grade postoperative complications (OR 0.4; p¼0.026), whereas only a non-significant trend was identified for high grade complications (OR 0.3; p¼0.05). Median followup duration of the patients alive and disease free was 26.6 mo (IQR 8.7-39 mo) and 30 mo (IQR 13 -64 mo) in the PN and RN group, respectively (p¼0.5). The two-year RFS, CSS and OS survival estimates were 91.8%, 94.0%, 88.1%, for PN, respectively, and 95.8%, 94.6%, 92.9% for RN, respectively. PN site of recurrence were: local in 3 (4,9%), nodal in 3 (4,9%) and distant in 11 (18%). No differences in RFS, CSS and OS survival estimates were found between PN and RN, both in UVA and MVA analyses, where only the classic pathological variables were independent predictors of RFS, CSS, and OS. Preoperative eGFR was similar in both groups, with roughly 3% of the patients presenting with ESRD at initial diagnosis. At follow-up, eGFR was similar in both groups, whereas the prevalence of ESRD was significantly higher in the PN group (32.7% vs 13.2%, p<0.01). However, in MVA analyses, baseline eGFR was the only independent predictor of ESRD (HR 1.0; p<0.01), whereas only a non-significant trend was identified for the type of surgery (HR 0.5; p¼0.07).
CONCLUSIONS: PN in tumors with concomitant intraparenchymal vein branches thrombosis is feasible but it is associated with higher risk of complications. RFS, CSS and OS were similar in the two groups. Finally, we found a non-statistically significant trend in favor of PN for ESRD prevention. While renal mass biopsy can aid in the identification of high grade disease, tools to predict tumor upstaging are limited. Given that preoperative risk factors associated with pT3a upstaging are not well defined we sought to identify predictors of pT3a disease in patients undergoing PNx for cT1 disease.
Source of Funding: None
METHODS: A retrospective chart review was completed to identify patients with cT1 renal masses who underwent open or minimally-invasive PNx between 2000-2014. All patients with imaging sufficient for R.E.N.A.L Nephrometry scoring were included. The primary outcome was upstaging to pT3a disease at final pathology. All patients with benign final pathology were excluded. Univariate and multivariate logistic regression analyses were performed to identify characteristics independently associated with pT3a upstaging. All variables with a pvalue of 0.1 on univariate analysis were included in the multivariate analysis.
RESULTS: A total of 508 patients were identified, of which 449 (88%) had final pT1 and 59 (12%) had final pT3a disease. The etiology of pT3a upstaging was perinephric adipose extension in 69% (41/59), renal sinus fat invasion in 28% (14/59), and microscopic segmental or renal vein invasion in 7% (4/59). Patient age (p¼0.012), ASA classification (p¼0.005), preoperative radiologic tumor size (p¼0.079), and high R.E.N.A.L Nephrometry Score complexity (p¼0.017) were all associated with pT3a upstaging on univariate analysis. Multivariate analysis demonstrated a significant and independent association of patient age (p¼0.025), preoperative radiologic tumor size (p¼0.014), and high R.E.N.A.L Nephrometry Score complexity (p¼0.019) with pT3a upstaging.
CONCLUSIONS: In patients who undergo PNx for cT1 disease, patient age, preoperative radiologic tumor size, and high R.E.N.A.L Nephrometry Score complexity represent readily measurable preoperative characteristics that are associated with increased risk of pT3a upstaging. The presence of these features may be utilized for operative planning to ensure adequate resection and negative margins in patients at increased risk for pathologic upstaging.
